Home/Filings/4/0001209191-13-012434
4//SEC Filing

Combes Genevieve Claire 4

Accession 0001209191-13-012434

CIK 0001142512other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:50 PM ET

Size

22.2 KB

Accession

0001209191-13-012434

Insider Transaction Report

Form 4
Period: 2013-02-27
Combes Genevieve Claire
SVP, Tech. & Ops. Strategy
Transactions
  • Award

    Stock Option (right to buy)

    2013-02-27+33,33333,333 total
    Exercise: $1.25From: 2013-02-27Exp: 2022-03-07Common Stock (33,333 underlying)
Holdings
  • Common Stock

    16,748
  • Stock Option (right to buy)

    Exercise: $2.90From: 2012-03-05Exp: 2021-03-04Common Stock (60,000 underlying)
    60,000
  • Stock Option (right to buy)

    Exercise: $4.90From: 2011-03-04Exp: 2020-03-03Common Stock (35,000 underlying)
    35,000
  • Stock Option (right to buy)

    Exercise: $4.97From: 2009-05-21Exp: 2018-05-20Common Stock (45,000 underlying)
    45,000
  • Stock Option (right to buy)

    Exercise: $7.11From: 2008-03-27Exp: 2017-03-26Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    Exercise: $3.20From: 2009-08-01Exp: 2016-07-23Common Stock (4,167 underlying)
    4,167
  • Stock Option (right to buy)

    Exercise: $3.20From: 2009-08-01Exp: 2016-07-23Common Stock (2,500 underlying)
    2,500
  • Stock Option (right to buy)

    Exercise: $3.20From: 2009-08-01Exp: 2016-07-23Common Stock (5,834 underlying)
    5,834
  • Stock Option (right to buy)

    Exercise: $3.20From: 2009-08-01Exp: 2016-07-23Common Stock (10,000 underlying)
    10,000
  • Stock Option (right to buy)

    Exercise: $3.20From: 2009-08-01Exp: 2016-07-23Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    Exercise: $5.97From: 2007-08-09Exp: 2016-08-08Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    Exercise: $1.25From: 2013-03-08Exp: 2022-03-07Common Stock (33,334 underlying)
    33,334
  • Stock Option (right to buy)

    Exercise: $1.25From: 2013-03-08Exp: 2022-03-07Common Stock (33,333 underlying)
    33,333
Footnotes (4)
  • [F1]One-fourth of the shares subject to the option vest and become exercisable on the Exercisable Date, and one forty-eighth of the shares vest and become exercisable on the first day of each calendar month thereafter.
  • [F2]The shares subject to the option are fully vested.
  • [F3]One-fourth of the shares subject to the option shall vest and become exercisable on March 8, 2013, and one forty-eighth of the shares shall vest and become exercisable on the first day of each calendar month thereafter; provided, however, that the option will accelerate and vest in full if the Company's closing stock price on the NASDAQ Stock Market is equal to or greater than $5.00 per share for a period of 120 consecutive days.
  • [F4]On March 8, 2012, the reporting person was granted an option to purchase 33,333 shares of common stock. This option would vest in full on the date that the Compensation Committee determined that the Company had achieved adjusted EBITDA profitability for full year 2012, and it would be forfeited if the Compensation Committee determined that the vesting event had not occurred. On February 27, 2013, the Compensation Committee determined that the vesting event had occurred, and the option vested in full.

Issuer

ZIPREALTY INC

CIK 0001142512

Entity typeother

Related Parties

1
  • filerCIK 0001383909

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:50 PM ET
Size
22.2 KB